BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 15, 2018
View Archived Issues
Phase I/II trial of bacteriophage therapy for the treatment of burn wounds infected by P. aeruginosa
Read More
Tryptophan metabolites contribute to multiple sclerosis risk and disease course in children
Read More
Fat receptors play role in obesity-associated pain
Read More
Triple mutant Parkinson's protein is toxic when it cannot form tetramers
Read More
ALS mutations can affect different neurons in different ways
Read More
Stronger together: combination treatment rescues CFTR folding
Read More
BMS and Compugen collaborate on studies of COM-701 plus Opdivo
Read More
SHIP2 is key in FGF signaling and necessary for the maintenance of FGF-mediated ERK activation
Read More
MEI Pharma and BeiGene to test combination of ME-401 and zanubrutinib
Read More
Phase II trial of neoadjuvant immune checkpoint blockade in high-risk resectable melanoma patients
Read More
Otsuka Pharmaceutical and Proteus Digital Health expand digital medicine collaboration
Read More
First results of elezanumab in patients with relapsing MS
Read More
Merck KGaA presents first-in-human data for evobrutinib
Read More
One-year interim analysis data presented from CHORDS study of ocrelizumab in RRMS
Read More
Novel inflammatory markers of poor clinical outcome in patients with S. aureus infection
Read More
Final phase II results of ublituximab in relapsing multiple sclerosis
Read More
Daewoong Pharmaceutical describes new BTK and/or JAK3 inhibitors
Read More
Serine-protein kinase ATM inhibitors patented by AstraZeneca
Read More
InSys and UC San Diego add third study to cannabidiol collaboration
Read More
Impetis Biosciences identifies succinate receptor 1 antagonists
Read More
Argonaut Therapeutics patents protein arginine N-methyltransferase 5 inhibitors
Read More
Gedeon Richter synthesizes GABA-B receptor positive allosteric modulators
Read More
FDA approves Xarelto to reduce risk of major CV events in coronary or peripheral artery disease
Read More
Farnesoid X receptor agonists identified at Metacrine
Read More
Iovance holds end of phase II meeting for lifileucel
Read More
Progenics plans phase II trial of 1095 for metastatic castration-resistant prostate cancer
Read More
Targovax reports DFS data from phase I/II trial of TG-01 in resected pancreatic cancer
Read More
NIH grant supports work on Feldan Shuttle to deliver CRISPR nucleases to airway epithelia
Read More
CheckMate-331 study of Opdivo in relapsed SCLC does not meet primary endpoint
Read More
Sanofi initiates first-in-human study of SAR-440234 in ALL, AML and MDS
Read More
FDA approves Yutiq for chronic noninfectious posterior segment uveitis
Read More
Australian TGA clears Peptilogics to begin phase I study of PLG-0206
Read More
